Amit Hasija
CIK: 0001787700
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (20.0%)
Position reduction
Option Exercises (M)1 (10.0%)
Derivative conversions
Awards (A)7 (70.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
MIST
Milestone Pharmaceuticals Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History
About Hasija Amit
Hasija Amit (SEC CIK 0001787700) files insider reports with the SEC as CFO & EVP of Corp. Development of Milestone Pharmaceuticals Inc. (MIST).
Signal8 holds 5 ownership filings by Hasija Amit, all Form 4s, filed between Jan 29, 2025 and Feb 5, 2026. Those filings report 10 transactions, from Jan 27, 2025 to Feb 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Hasija Amit's filings is in MONTREAL, A8.
Other insiders filing for Milestone Pharmaceuticals Inc. (MIST)
- Giles Lisa M., Director
- Fischer Seth H. Z., Director
- Duty Stuart, Director
- Wills Robert James, Director
- TOMSICEK MICHAEL JOHN, Director
- Saik Andrew, Director